Entyvio (vedolizumab) Drug Market Report

China Entyvio (vedolizumab) Drug Industry Market Research Report 2023-2029

  • POSTDATE：Oct 15, 2023
  • PAGES：135
  • REPORT CODE：GMM1855832
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn’s disease.

    This report elaborates on the current development of the Entyvio (vedolizumab) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Takeda

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Crohn's Disease

    • Ulcerative Colitis

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Entyvio (vedolizumab) Drug Market Overview 2018-2029

    • 1.1 China Entyvio (vedolizumab) Drug Industry Development Overview

    • 1.2 China Entyvio (vedolizumab) Drug Industry Development History

    • 1.3 China Entyvio (vedolizumab) Drug Industry Market Size (2018-2029)

    • 1.4 China Entyvio (vedolizumab) Drug Market Analysis by Type from Production Side

      • 1.4.1 China Entyvio (vedolizumab) Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Entyvio (vedolizumab) Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Entyvio (vedolizumab) Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Entyvio (vedolizumab) Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Entyvio (vedolizumab) Drug Sales Volume, Sales Value and Growth Rate of Crohn's Disease (2018-2029)

      • 1.5.2 China Entyvio (vedolizumab) Drug Sales Volume, Sales Value and Growth Rate of Ulcerative Colitis (2018-2029)

    • 1.6 China Entyvio (vedolizumab) Drug Market Analysis by Region

      • 1.6.1 North China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Entyvio (vedolizumab) Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Entyvio (vedolizumab) Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Entyvio (vedolizumab) Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Entyvio (vedolizumab) Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Entyvio (vedolizumab) Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Entyvio (vedolizumab) Drug Industry Development

    Chapter 3 Entyvio (vedolizumab) DrugIndustry Chain Analysis

    • 3.1 Entyvio (vedolizumab) Drug Industry Chain

    • 3.2 Entyvio (vedolizumab) Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Entyvio (vedolizumab) Drug Market

    • 3.3 Entyvio (vedolizumab) Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Entyvio (vedolizumab) Drug Market

    Chapter 4 China Entyvio (vedolizumab) Drug Market, by Type

    • 4.1 China Entyvio (vedolizumab) Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Entyvio (vedolizumab) Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Entyvio (vedolizumab) Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Entyvio (vedolizumab) Drug Production Volume and Growth Rate of Type 1

      • 4.5.2 China Entyvio (vedolizumab) Drug Production Volume and Growth Rate of Type 2

      • 4.5.3 China Entyvio (vedolizumab) Drug Production Volume and Growth Rate of Type 3

    Chapter 5 China Entyvio (vedolizumab) Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Entyvio (vedolizumab) Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Entyvio (vedolizumab) Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Entyvio (vedolizumab) Drug Market Size and Growth Rate of Crohn's Disease

      • 5.5.2 China Entyvio (vedolizumab) Drug Market Size and Growth Rate of Ulcerative Colitis

    Chapter 6 China Entyvio (vedolizumab) Drug Market, by Region

    • 6.1 China Entyvio (vedolizumab) Drug Production Volume and Production Value, by Region

    • 6.2 China Entyvio (vedolizumab) Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Entyvio (vedolizumab) Drug Market Analysis

    • 7.1 North China Entyvio (vedolizumab) Drug Market, by Type

    • 7.2 North China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 8 Central China Entyvio (vedolizumab) Drug Market Analysis

    • 8.1 Central China Entyvio (vedolizumab) Drug Market, by Type

    • 8.2 Central China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 9 South China Entyvio (vedolizumab) Drug Market Analysis

    • 9.1 South China Entyvio (vedolizumab) Drug Market, by Type

    • 9.2 South China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 10 East China Entyvio (vedolizumab) Drug Market Analysis

    • 10.1 East China Entyvio (vedolizumab) Drug Market, by Type

    • 10.2 East China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 11 Northeast China Entyvio (vedolizumab) Drug Market Analysis

    • 11.1 Northeast China Entyvio (vedolizumab) Drug Market, by Type

    • 11.2 Northeast China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 12 Southwest China Entyvio (vedolizumab) Drug Market Analysis

    • 12.1 Southwest China Entyvio (vedolizumab) Drug Market, by Type

    • 12.2 Southwest China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 13 Northwest China Entyvio (vedolizumab) Drug Market Analysis

    • 13.1 Northwest China Entyvio (vedolizumab) Drug Market, by Type

    • 13.2 Northwest China Entyvio (vedolizumab) Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Takeda

        • 14.1.1 Takeda Company Profile

        • 14.1.2 Takeda Entyvio (vedolizumab) Drug Market Performance

        • 14.1.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Entyvio (vedolizumab) Drug Industry Research Conclusions

    • 15.2 Entyvio (vedolizumab) Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Entyvio (vedolizumab) Drug Industry Market Size (2018-2029)

    • Figure China Entyvio (vedolizumab) Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Entyvio (vedolizumab) Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Entyvio (vedolizumab) Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Entyvio (vedolizumab) Drug Sales Volume, Sales Value and Growth Rate of Crohn's Disease (2018-2029)

    • Figure China Entyvio (vedolizumab) Drug Sales Volume, Sales Value and Growth Rate of Ulcerative Colitis (2018-2029)

    • Figure North China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Entyvio (vedolizumab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Entyvio (vedolizumab) Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Entyvio (vedolizumab) Drug Market Share by Type in 2018

    • Figure China Entyvio (vedolizumab) Drug Market Share by Type in 2023

    • Figure China Entyvio (vedolizumab) Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Market Share by Application in 2018

    • Figure China Entyvio (vedolizumab) Drug Market Share by Application in 2023

    • Figure China Entyvio (vedolizumab) Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Entyvio (vedolizumab) Drug Market Size and Growth Rate of Crohn's Disease (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Market Size and Growth Rate of Ulcerative Colitis (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Production Volume by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Production Volume Share by Region (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Production Volume Share by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Production Value by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Production Value Share by Region (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Production Value Share by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Sales Volume by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Sales Volume Share by Region (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Sales Volume Share by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Sales Value by Region (2018-2023)

    • Table China Entyvio (vedolizumab) Drug Sales Value Share by Region (2018-2023)

    • Figure China Entyvio (vedolizumab) Drug Sales Value Share by Region (2018-2023)

    • Table North China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table North China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure North China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table North China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table North China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table Central China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table Central China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table Central China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table South China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table South China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure South China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table South China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table South China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table East China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table East China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure East China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table East China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table East China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table Northeast China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table Southwest China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Entyvio (vedolizumab) Drug Production Volume by Type (2018-2023)

    • Table Northwest China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Entyvio (vedolizumab) Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Entyvio (vedolizumab) Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Entyvio (vedolizumab) Drug Sales Volume Share by Application (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Entyvio (vedolizumab) Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US